GL1X · GenesisL1 explorer

MolNFT v1 · #262855 · protein

AlphaFold monomer V2.0 prediction for neurabin-2 (O35274)

O35274: “AlphaFold monomer V2.0 prediction for neurabin-2 (O35274)”. 4 pockets (best druggability 0.56). MolNFT v1 #262855 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

Accession
O35274
Type
protein
Length
817 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x7012c0b45c68a2c067644b9d3e5DDa06892c6957
Molecule
Neurabin-2
UniProt
O35274
Pockets
4 · best druggability 0.56

Structure

1 distinct chain · 31% helix, 6% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANeurabin-2protein81731% helix, 6% strandO35274

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12600.560.7733empty
22170.530.7731empty
3590.380.8016empty
4510.280.769empty

Compared structures

  • 3EGH · Crystal structure of a complex between protein phosphatase 1 alpha (PP1), the PP1 binding… · an experimental structure of the same protein · chain A against C, TM-score 0.19
  • 3EGH · Crystal structure of a complex between Protein Phosphatase 1 alpha (PP1), the PP1 binding… · an experimental structure of the same protein · chain A against C, TM-score 0.19
  • 3EGG · Crystal structure of a complex between protein phosphatase 1 alpha (PP1) and the PP1… · an experimental structure of the same protein · chain A against C, TM-score 0.19
  • 3EGG · Crystal structure of a complex between Protein Phosphatase 1 alpha (PP1) and the PP1… · an experimental structure of the same protein · chain A against C, TM-score 0.19
  • 2G5M · Spinophilin PDZ domain · an experimental structure of the same protein · chain A against B, TM-score 0.11
  • 2G5M · Spinophilin PDZ domain · an experimental structure of the same protein · chain A against B, TM-score 0.11

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.